Ironwood Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $0.20 | $0.21 | $0.20 |
| Q2 2024 | 1 | $0.16 | $0.16 | $0.16 |
| Q3 2024 | 1 | $0.07 | $0.07 | $0.07 |
| Q4 2024 | 3 | $0.05 | $0.06 | $0.06 |
| Q1 2025 | 2 | $0.02 | $0.04 | $0.03 |
| Q2 2025 | 1 | $0.03 | $0.03 | $0.03 |
| Q3 2025 | 1 | $0.06 | $0.06 | $0.06 |
| Q4 2025 | 1 | $0.05 | $0.06 | $0.06 |
Ironwood Pharmaceuticals, Inc. Earnings Date And Information
Ironwood Pharmaceuticals, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $0.02 earnings per share for the quarter, missing analysts' consensus estimates of $0.08 by $0.06. The company had revenue of 91.59 M for the quarter and had revenue of 442.74 M for the year. Ironwood Pharmaceuticals, Inc. has generated $-6 earnings per share over the last year ($-6.45 diluted earnings per share) and currently has a price-to-earnings ratio of 25.7. Ironwood Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based on prior year's report dates.
Ironwood Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | $0.08 | $0.19 | 0.11 | $91.22 M | $91.59 M |
| 08/08/2024 | Q2 2024 | $0.15 | -$0.01 | -0.16 | $107.10 M | $94.40 M |
| 05/09/2024 | Q1 2024 | $0.18 | -$0.03 | -0.21 | $74.88 M | |
| 02/16/2024 | Q4 2023 | -$0.01 | $117.55 M | |||
| 11/09/2023 | Q3 2023 | $0.16 | $0.10 | -0.06 | $114.00 M | $113.74 M |
| 08/09/2023 | Q2 2023 | -$6.84 | $103.70 M | $107.38 M | ||
| 05/04/2023 | Q1 2023 | $0.24 | $0.30 | 0.06 | $104.06 M | |
| 02/16/2023 | Q4 2022 | $0.27 | $0.32 | 0.05 | $107.20 M | |
| 11/03/2022 | Q3 2022 | $0.27 | $0.28 | 0.01 | $109.15 M | $108.64 M |
| 08/04/2022 | Q2 2022 | $0.30 | $0.24 | -0.06 | $103.55 M | $97.23 M |
| 05/05/2022 | Q1 2022 | $0.26 | $0.21 | -0.05 | $97.53 M | |
| 02/17/2022 | Q4 2021 | $0.25 | $117.13 M | |||
| 11/04/2021 | Q3 2021 | $0.31 | $0.34 | 0.03 | $105.28 M | $103.75 M |
| 08/05/2021 | Q2 2021 | $0.23 | $2.42 | 2.19 | $93.85 M | $104.03 M |
| 05/06/2021 | Q1 2021 | $0.21 | $0.25 | 0.04 | $88.85 M | |
| 02/17/2021 | Q4 2020 | $0.27 | $0.27 | 0 | $116.68 M | |
| 11/05/2020 | Q3 2020 | $0.15 | $0.22 | 0.07 | $93.10 M | $103.47 M |
| 08/06/2020 | Q2 2020 | $0.09 | $0.16 | 0.07 | $84.76 M | $89.43 M |
| 05/06/2020 | Q1 2020 | $0.11 | $0.02 | -0.09 | $79.94 M | |
| 02/13/2020 | Q4 2019 | $0.24 | $0.31 | 0.07 | $126.30 M |
Ironwood Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Ironwood Pharmaceuticals, Inc.'s earnings date?
Ironwood Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based off last year's report dates.
-
How can I listen to Ironwood Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Ironwood Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Ironwood Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Ironwood Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does Ironwood Pharmaceuticals, Inc. generate each year?
Ironwood Pharmaceuticals, Inc. (:IRWD) has a recorded annual revenue of $442.74 M.
-
How much profit does Ironwood Pharmaceuticals, Inc. generate each year?
Ironwood Pharmaceuticals, Inc. (:IRWD) has a recorded net income of $442.74 M. Ironwood Pharmaceuticals, Inc. has generated $-6.45 earnings per share over the last four quarters.
-
What is Ironwood Pharmaceuticals, Inc.'s price-to-earnings ratio?
Ironwood Pharmaceuticals, Inc. (:IRWD) has a price-to-earnings ratio of 25.7 and price/earnings-to-growth ratio is 0.17.
